Healthcare news on August 13, 2026

1. 0114:30 UTC

   Reports: lenacapavir trial data show sustained HIV protection

   3 outlets · first: kyuk.org Market trends

   Machine summary Key facts from the reports:

   1. Reports state lenacapavir is currently only approved for HIV-negative individuals to prevent infection, known as pre-exposure prophylaxis (PrEP).
   2. According to the reports, an independent monitoring committee concluded lenacapavir was so effective that the randomized phase of the PURPOSE 1 and 2 trials should be stopped early.

   Reported by kyuk.org, wfdd.org and kwbu.org.

   • Lenacapavir
   • PURPOSE 1

2. 0214:45 UTC

   Medicare for All vs $40T Debt: Maine Senate Race Health Divide

   2 outlets · first: pressherald.com Regulation

   Machine summary In Maine's Senate race, Troy Jackson supports Medicare for All, while Susan Collins says it is expensive and impractical amid a national debt nearing $40 trillion. For the nation's oldest state by median age, the proposal includes long-term care, dental, vision, and drug benefits.

   1. The national debt is approaching $40 trillion, which Collins frames as a barrier to expanding Medicare.
   2. Maine is the oldest state in the nation by median age. Healthcare is an issue in the Senate race.

   Reported by pressherald.com and centralmaine.com.

   • Susan Collins

3. 0314:30 UTC

   Oma's Pride recalls frozen raw dog food over salmonella

   2 outlets · first: fox4news.com Regulation

   Machine summary Oma's Pride of Avon, Connecticut, is recalling 639 bags of its 6-pound Woof Complete Canine Chicken Recipe frozen raw dog food because of salmonella contamination, according to the U.S. Food and Drug Administration. The recalled lot was distributed in 11 states and directly to consumers, the FDA said. The company said it is conducting further investigation.

   Reported by fox4news.com and foxla.com.

   • Food and Drug Administration
   • Salmonella
   • Oma's Pride
   • Woof Complete Canine Chicken Recipe

4. 0414:30 UTC

   Ukraine health ministry begins technical assessment of Valion Bio's Entolimod dossier

   2 outlets · first: finanznachrichten.de Regulation

   Machine summary Valion Bio, Inc. said Ukraine's Ministry of Health accepted its regulatory dossier for Entolimod for formal review on July 22, 2026, and has begun technical assessment, issuing a first round of questions.

   1. Valion Bio said Ukraine's Ministry of Health accepted its regulatory dossier for Entolimod for formal review on July 22, 2026.
   2. According to Valion Bio, the ministry has begun a technical assessment and sent an initial set of questions about the physicochemical characterization of the drug product, which, under a potential arrangement for stockpiling, would be supplied.
   3. Valion Bio said no procurement, purchase, or stockpiling agreement has been executed.

   Reported by finanznachrichten.de and hawaiitelegraph.com (Big News Network).

   • Valion Bio, Inc.
   • Ukraine Ministry of Health
   • Entolimod

5. 0522:32 UTC

   Coverage recordMotley Fool: “Omada Health (OMDA) Q2 2026 Earnings Call Transcript”

   1 outlet · first: Motley Fool

   Reports ran from 22:32 UTC on Aug 13 to 00:15 UTC on Aug 14.

   The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

   Reported by Motley Fool and fool.com.

   • Omada Health

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.